• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Molecular epidemiology of cancers and precancerous conditions].

作者信息

Ember István, Kiss István, Sándor János, Varga Csaba, Gyöngyi Zoltán, Németh Katalin, Fehér Katalin, Lukács Péter, Dombi Zsuzsanna

机构信息

Pécsi Tudományegyetem, Altalános Orvostudományi Kar, Közegészségtani Intézet, Pécs.

出版信息

Orv Hetil. 2004 Mar 7;145(10):507-14.

PMID:15085589
Abstract

For many years the molecular biology has been one of the most promising fields of science and its several methods have been used in practice. These new methods of molecular biology made impression on epidemiology and developed a new discipline, called molecular epidemiology. The molecular and predictive epidemiology play more and more important roles in the prevention of cancers. Early biomarkers could identify the high risk population to have the possibilities of primary preventive interventions. It uses both molecular biological methods and the elements of epidemiology. Its specificity is not high enough to establish the diagnosis but it can be used to follow the "minimal residual disease" and with markers of individual susceptibility, to assess the risk of tumors. As to the practice there are many problems because of the limited therapeutic possibilities, but the molecular and predictive epidemiology becomes an important part of medicine in the future.

摘要

相似文献

1
[Molecular epidemiology of cancers and precancerous conditions].
Orv Hetil. 2004 Mar 7;145(10):507-14.
2
Molecular epidemiology: new rules for new tools?
Mutat Res. 2006 Aug 30;600(1-2):3-11. doi: 10.1016/j.mrfmmm.2006.05.033. Epub 2006 Jul 14.
3
Landmarks in the history of cancer epidemiology.癌症流行病学史上的里程碑。
Cancer Res. 2009 Mar 15;69(6):2151-62. doi: 10.1158/0008-5472.CAN-09-0416. Epub 2009 Mar 10.
4
Cancer risk assessment and cancer prevention: promises and challenges.癌症风险评估与癌症预防:前景与挑战。
Cancer Prev Res (Phila). 2008 Sep;1(4):229-32. doi: 10.1158/1940-6207.CAPR-08-0113.
5
[Molecular markers of head and neck cancer].[头颈癌的分子标志物]
Rev Prat. 2006 Oct 15;56(15):1658-61.
6
[Markers of exposure and early lesions in cancer epidemiology].[癌症流行病学中的暴露标志物与早期病变]
Rev Epidemiol Sante Publique. 1985;33(4-5):304-11.
7
Systems epidemiology in cancer.癌症中的系统流行病学
Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):2954-7. doi: 10.1158/1055-9965.EPI-08-0519.
8
Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program.无癌重度吸烟者自发性痰液中的分子改变:一项大型筛查项目的结果
Clin Cancer Res. 2008 Mar 15;14(6):1913-9. doi: 10.1158/1078-0432.CCR-07-1741.
9
Biomarkers and molecular epidemiology--present state and future trends: concluding remarks.生物标志物与分子流行病学——现状与未来趋势:结束语
Mutat Res. 2006 Aug 30;600(1-2):77-8. doi: 10.1016/j.mrfmmm.2006.05.035. Epub 2006 Jun 27.
10
Integrative epidemiology: from risk assessment to outcome prediction.整合性流行病学:从风险评估到结果预测
J Clin Oncol. 2005 Jan 10;23(2):267-75. doi: 10.1200/JCO.2005.05.122.